Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Kisspeptin in PCOS
NCT05971849Phase 1Completed
- Start
- Oct 2023
- Primary completion
- Apr 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of kisspeptin in polycystic ovary syndrome (PCOS). Primary endpoints: Average change in LH pulse frequency at 6 hours and Average change in LH pulse amplitude at 6 hours. Started Oct 2023; status: completed.
02
Drugs
kisspeptin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05971849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05971849.